Fabbro BioPharm Consulting SRL
Fabbro BioPharm Consulting reported total assets of 757,898 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Apr 2026).
By total assets for 2025, Fabbro BioPharm Consulting ranks among the 1,000 largest of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Fabbro BioPharm Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +74 % Total assets +78 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fabbro BioPharm Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 113,359 € | ||||
| Equity | 732,063 € | ||||
| Cash | 713,856 € | ||||
| EBITDA | 158,224 € | ||||
| Total assets | 757,898 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 28 Apr 2026
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 04 Mar 2024
- Year ended 30 Sep 2022filed on 15 Mar 2023
- Year ended 30 Sep 2021filed on 24 Mar 2022
Fabbro BioPharm Consulting's financial analysis
- Solvency96.6%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fabbro BioPharm Consulting
Fabbro BioPharm Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0739.732.886
- VAT number
- BE0739732886
- Peppol
- Registered · 0208:0739732886 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 2019
- Registered office
- 8570 Anzegem
- Latest accounts
- 2025 · filed on 28 Apr 2026
- Activity
- Public relations and communication activities (NACE 73300)
Fabbro BioPharm Consulting (SRL) has been based in Anzegem since 2019, active in: public relations and communication activities. For 2025, it reports a net profit of 113,359 € and equity of 732,063 €; its revenue is not published. Its solvency stands at 96.6%, above the median of its sector (56.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Fabbro BioPharm Consulting
Companies in the same business, of comparable size and area, outside its group.
- SÛR+ Public relations and communication activities Izegem · balance sheet 755,226 €
- Kairos Inc. Public relations and communication activities Bierbeek · balance sheet 754,818 €
- Triumphus Public relations and communication activities Chastre · balance sheet 740,914 €
- Ecothem Public relations and communication activities Keerbergen · balance sheet 767,746 €
- Double You.BE Public relations and communication activities Kortenberg · balance sheet 781,760 €
- MVP² Public relations and communication activities Ixelles · balance sheet 785,662 €
- The Little Box Public relations and communication activities Dilbeek · balance sheet 730,566 €
- TribeAffair Public relations and communication activities Nazareth-De Pinte · balance sheet 730,104 €
Frequently asked questions about Fabbro BioPharm Consulting
What is the revenue of Fabbro BioPharm Consulting?
Fabbro BioPharm Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fabbro BioPharm Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0739732886 for Fabbro BioPharm Consulting, if the company is VAT-registered. Its company number (CBE) is 0739.732.886.
Where is the registered office of Fabbro BioPharm Consulting?
According to the CBE register, the registered office of Fabbro BioPharm Consulting is in 8570 Anzegem.
What is the equity of Fabbro BioPharm Consulting?
At the close of the 2025 financial year, the equity of Fabbro BioPharm Consulting amounts to 732,063 €, a solvency of 96.6% of total assets.
Who manages Fabbro BioPharm Consulting?
The register lists 1 active mandates at Fabbro BioPharm Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Fabbro BioPharm Consulting within its sector?
By total assets for 2025, Fabbro BioPharm Consulting ranks among the 1,000 largest of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year.
The full file of Fabbro BioPharm Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →